A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome
Clinical trial NCT05643794 · COMPLETED
Trial details
- NCT number
- NCT05643794
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-21
- Primary completion
- 2024-05-28
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.